Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Chinese Medical Journal|May 6, 2014
Bortezomib improves progression-free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanomaYazhen Qin, Jin Lu, Li Bao, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|February 22, 2023
Evaluating the antioxidant activity of secondary metabolites of endophytic fungi from Hypericum perforatum L. by an electrochemical biosensor based on AuNPs/AC@CS compositeBolu Sun, Yanmei Yang, Yanlei Sun, et al.
Annals of Hematology|June 21, 2024
Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese studyLeyu Wang, Liwei Fang, Hongxia Shi, et al.
Bioelectrochemistry (Amsterdam, Netherlands)|June 24, 2026
Design and application of a FA-based molecularly imprinted sensor for screening anti-Fusariumoxysporum substances from Lanzhou lily endophytesXinlan Wang, Xiangdong Wang, Bolu Sun, et al.
Oncotarget|December 30, 2017
CD20 expression sub-stratifies standard-risk patients with B cell precursor acute lymphoblastic leukemiaShenMiao Yang, Jing Wang, Ting Zhao, et al.
British Journal of Haematology|June 27, 2020
The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosisWenbing Duan, Xiaohong Liu, Jinsong Jia, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 8, 2018
RIP140/PGC-1α axis involved in vitamin A-induced neural differentiation by increasing mitochondrial functionQing Mu, Weidong Yu, Shuying Zheng, et al.
Annals of Hematology|August 12, 2023
Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemiaWenbing Duan, Sen Yang, Ting Zhao, et al.
Annals of Hematology|January 21, 2021
Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single centerWenbing Duan, Xiaohong Liu, Xiaosu Zhao, et al.
Annals of Hematology|March 5, 2024
Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome-positive acute lymphoblastic leukaemiaLijuan Hu, Zongru Li, Sen Yang, et al.
Pageof 5